更年期市场规模、份额、增长分析、按治疗方法、产品类型、适应症、分销挑战、年龄组和地区划分 - 行业预测 2025-2032

预计 2023 年全球更年期疾病市场规模将达到 186 亿美元，从 2024 年的 197.2 亿美元增长到 2032 年的 314.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.0%。

更年期市场正在崛起，反映出人们对缓解更年期症状（如潮热、盗汗和忧郁等）的产品的认识和需求不断增长。这种自然的生物学变化发生在 45 岁至 55 岁之间，引发了人们对旨在缓解症状的膳食补充剂、草药产品和非处方药的兴趣激增。推动这一增长的因素包括人口老化、健康意识的增强以及向自然和有机解决方案的转变。 COVID-19 疫情进一步加剧了这些趋势，扰乱了心理健康，鼓励女性寻求安全的植物来源荷尔蒙补充疗法替代品，并促进了膳食补充剂的使用。这种不断变化的情况为市场持续扩张提供了机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

更年期障碍市场规模（依治疗方法和复合年增长率） (2025-2032)

• 市场概览
• 营养补充品
• 非处方药
  • 荷尔蒙产品
  • 雌激素与其他药物的合併使用
  • 雌激素加黄体素联合药物
  • 仅含雌激素的药物
  • 仅含黄体素的药物
  • 非荷尔蒙产品

更年期障碍市场规模（按产品类型和复合年增长率） （2025-2032）

• 市场概览
• 凝胶
• 注射
• 口服剂量
• 修补
• 丸
• 粉末
• 保养霜
• 皮肤喷雾（经皮）
• 阴道软膏
• 避孕环

更年期障碍市场规模（按适应症和复合年增长率） (2025-2032)

• 市场概览
• 眼睛干涩
• 皮肤干燥
• 潮热
• 情绪波动、轻度忧郁症、易怒
• 盗汗和发冷
• 骨质疏鬆症
• 睡眠障碍
• 尿急
• 阴道干燥

更年期障碍市场规模（按分布问题和复合年增长率） (2025-2032)

• 市场概览
• 医院药房
• 网路商店
• 零售药局

更年期障碍市场规模（依年龄层及复合年增长率） (2025-2032)

• 市场概览
• 过早停经
• 早期停经
• 平均更年期
• 停经晚期

更年期障碍市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• AbbVie Inc.（USA）
• Astellas Pharma Inc.（Japan）
• Bayer AG（Germany）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Merck & Co., Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Eli Lilly and Company（USA）
• GlaxoSmithKline plc（UK）
• Key Developments
• Mithra Pharmaceuticals（Belgium）
• Dr. Reddy's Laboratories Ltd.（India）
• Procter & Gamble（USA）
• Unilever（UK）
• Pure Encapsulations, LLC（USA）
• Rainbow Light（USA）
• Kindra（USA）
• Elektra Health（USA）

结论和建议

Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The menopause market is on an upward trajectory, reflecting heightened awareness and demand for products that alleviate menopausal symptoms such as hot flashes, night sweats, and mood swings, experienced by a significant percentage of women. Spanning ages 45 to 55, this natural biological transition has prompted a surge in interest for nutritional supplements, herbal products, and over-the-counter medications designed to ease symptoms. Factors fueling this growth include an aging population, increased health consciousness, and a shift toward natural and organic solutions. The COVID-19 pandemic has further intensified these trends, disrupting mental health and prompting women to seek safe, plant-based alternatives to hormone replacement therapy, resulting in a boost in dietary supplement usage. This evolving landscape signals sustained market expansion opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segments Analysis

Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Menopause Market

The global menopause market is fueled by several key factors, including the aging population, increased awareness, lifestyle changes, and advancements in technology. As life expectancies rise and birth rates decline, more women are entering menopause, creating a substantial demand for menopause-related products and services. For example, the North American Menopause Association reports that about 2 million women in the U.S. go through menopause each year. Additionally, public awareness of menopause symptoms is improving, leading to greater demand for solutions like hormone therapy, herbal supplements, and wellness products. Women are also acknowledging the role of healthy lifestyles in managing menopause symptoms, further driving market growth.

Restraints in the Global Menopause Market

Despite the substantial growth potential in the Global Menopause market, several factors may act as constraints on its expansion. Safety concerns regarding hormone replacement therapy (HRT), particularly its links to increased risks of breast cancer, heart disease, and stroke, are paramount. Consequently, there is a growing demand for non-hormonal alternatives, creating challenges for companies focusing on hormone-based therapies to address these safety issues. Additionally, menopause remains a stigmatized topic in many cultures, leading to a lack of awareness and understanding that can suppress consumer demand and complicate marketing efforts for menopause-related products. Regulatory hurdles impose strict safety and efficacy requirements, further deterring innovation in treatment options. Compounded by insufficient research and development in this field, these factors collectively threaten to hinder the market's advancement.

Market Trends of the Global Menopause Market

The Global Menopause market is witnessing a significant shift towards non-hormonal therapies driven by women's growing apprehension regarding hormone-based treatments and their associated risks. This trend has led to a rising demand for alternative solutions, such as herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based interventions, which are perceived as safer options for managing menopausal symptoms. As awareness around holistic health and wellness increases, healthcare providers and companies are focusing on developing and promoting these non-hormonal alternatives, further shaping the market landscape. This evolution highlights a consumer preference for natural and integrative approaches, signaling a transformative era in menopause management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Menopause Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Dietary Supplements
• OTC Pharma Products
  • Hormonal products
  • Combination Estrogen and Other Medicines
  • Combination Estrogen and Progestin Medicines
  • Estrogen-Only Medicines
  • Progestin-Only Medicines
  • Non-hormonal products

Global Menopause Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Gel
• Injection
• Oral Dosage
• Patch
• Pill
• Powder
• Skin Cream
• Skin Spray (Transdermal)
• Vaginal Cream
• Vaginal Ring

Global Menopause Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Dry Eyes
• Dry Skin
• Hot Flashes
• Mood Swings, Mild depression & Irritability
• Night Sweats and Cold Flashes.
• Osteoporosis
• Trouble Sleeping
• Urinary Urgency
• Vaginal Dryness

Global Menopause Market Size by Distribution Challenge & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Online Stores
• Retail Pharmacies

Global Menopause Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Premature Menopause
• Early Menopause
• Average Menopause
• Late Menopause

Global Menopause Market Size & CAGR (2025-2032)

• North America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • US
  • Canada
• Europe (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Mithra Pharmaceuticals (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unilever (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pure Encapsulations, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow Light (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindra (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elektra Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations